Iradimed CEO Sells 7,500 Shares Indirectly
Iradimed's CEO, Roger Susi, sold 7,500 shares of the company's stock indirectly through trust entities on April 20 and 21, 2026, for a total of approximately $694,125. The sale aligns with a pattern of periodic selling by the CEO over the past three years. The transaction does not involve direct shares held by the CEO, and post-transaction indirect holdings stand at 4,427,950 shares.
Tickers: $IRMD
Topics: executive share sales Iradimed Corporation SEC filings